DrugMapper
Browse
Therapeutic Area
CANCER (51)
CARDIOVASCULAR (45)
DENTISTRY (2)
DERMATOLOGY (31)
DIABETES DRUGS & ENDOCRINOLOGY (61)
EMERGENCY MEDICINE (3)
ENT (5)
EYE (23)
GASTROINTESTINAL (29)
HEMATOLOGY (23)
MUSCULOSKELETAL (28)
NEUROLOGY DRUGS & NERVOUS SYSTEM (50)
PEDIATRICS (27)
PHARMACOLOGY (8)
PREGNANCY AND GYNECOLOGY (30)
RESPIRATORY (42)
RHEUMATOLOGY (19)
OTHER (1482)
Therapeutic Indication
Adverse Reaction (System Organ Classification)
Mechanism of Action
Primary Target
Target Level
Level 1
Level 2
Level 3
Level 4
Level 5
Level 6
Active Pharmaceutical Ingredients (APIs)
Small Molecules
ProDrugs
Antibodies
CNS drugs
Metabolites
Search
Therapeutic Indication
Adverse Reaction (System Organ Classification)
Mechanism of Action
Target Sequence
Chemical Structure
Physicochemical Properties
Analyze
Networks
Chemical Similarity
Scaffold Similarity
KNIME workflow
Downloads
Web services
Bulk Downloads
About
DrugMapper FAQs
Data Sources
Contact Us
Display Options:
Drug type
Therapeutic Area
Route of administration
Mechanism of Action
Indication
Status
Total:
10647
OnabotulinumtoxinA
4
Unknown
Approved
DERMATOLOGY; MUSCULOSKELETAL; OTHER
SINGLE-USE
Unknown
Synaptosomal-associated protein 25 inhibitor
OnabotulinumtoxinA
×
Maximum Phase:
4
First Approval:
None
UNII:
Molecule Type:
Unknown
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
FERROUS CITRATE, FE-59
4
Small molecule
Approved
OTHER
INJECTION
Unknown
Unknown
FERROUS CITRATE, FE-59
×
Maximum Phase:
4
First Approval:
None
UNII:
Molecule Type:
Small molecule
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
ETHINYL ESTRADIOL; FERROUS FUMARATE; NORETHINDRONE
4
Combination
Approved
OTHER
ORAL-28
Unknown
Unknown
ETHINYL ESTRADIOL; FERROUS FUMARATE; NORETHINDRONE
×
Maximum Phase:
4
First Approval:
None
UNII:
Molecule Type:
Combination
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
POLYVINYL ALCOHOL
4
Small molecule
Approved
Unknown
Unknown
Fatigue
Unknown
POLYVINYL ALCOHOL
×
Maximum Phase:
4
First Approval:
None
UNII:
None
Molecule Type:
Small molecule
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
FOSTIMON
4
Unknown
Approved
Unknown
Unknown
Unknown
Unknown
FOSTIMON
×
Maximum Phase:
4
First Approval:
None
UNII:
Molecule Type:
Unknown
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
NICORANDIL
4
Small molecule
Approved
Unknown
Unknown
Dementia; Premature Birth; Radiation Pneumonitis; Myocardial Infarction; Severe Acute Respiratory Syndrome; Cardiovascular Diseases
Unknown
NICORANDIL
×
Maximum Phase:
4
First Approval:
None
UNII:
260456HAM0
Molecule Type:
Small molecule
Molecular Formula:
C8H9N3O4
Molecular Weight:
211.18
AlogP:
0.02
PSA:
94.36
HBD:
1.0
HBA:
#RotB:
5.0
Source:
TECHNETIUM TC-99M ALBUMIN MICROSPHERES KIT
4
Protein
Approved
OTHER
INJECTION
Unknown
Unknown
TECHNETIUM TC-99M ALBUMIN MICROSPHERES KIT
×
Maximum Phase:
4
First Approval:
None
UNII:
None
Molecule Type:
Protein
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
UREA, C-14
4
Small molecule
Approved
OTHER
ORAL
Unknown
Unknown
UREA, C-14
×
Maximum Phase:
4
First Approval:
None
UNII:
Molecule Type:
Small molecule
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
ACEFYLLINE
4
Small molecule
Approved
Unknown
Unknown
Unknown
Unknown
ACEFYLLINE
×
Maximum Phase:
4
First Approval:
None
UNII:
M494UE2YEP
Molecule Type:
Small molecule
Molecular Formula:
C9H10N4O4
Molecular Weight:
238.2
AlogP:
-1.48
PSA:
99.12
HBD:
1.0
HBA:
#RotB:
2.0
Source:
ISOPROTERENOL HYDROCHLORIDE; PHENYLEPHRINE BITARTRATE
4
Combination
Approved
OTHER
INHALATION
Unknown
Unknown
ISOPROTERENOL HYDROCHLORIDE; PHENYLEPHRINE BITARTRATE
×
Maximum Phase:
4
First Approval:
None
UNII:
Molecule Type:
Combination
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
CORD BLOOD
4
Unknown
Approved
Unknown
Unknown
Unknown
Unknown
CORD BLOOD
×
Maximum Phase:
4
First Approval:
None
UNII:
Molecule Type:
Unknown
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
BUTALBITAL; ACETAMINOPHEN; CAFFEINE; CODEINE PHOSPHATE
4
Combination
Approved
OTHER
ORAL
Unknown
Unknown
BUTALBITAL; ACETAMINOPHEN; CAFFEINE; CODEINE PHOSPHATE
×
Maximum Phase:
4
First Approval:
None
UNII:
Molecule Type:
Combination
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
CITRIC ACID; GLUCONOLACTONE; MAGNESIUM CARBONATE
4
Combination
Approved
OTHER
IRRIGATION
Unknown
Unknown
CITRIC ACID; GLUCONOLACTONE; MAGNESIUM CARBONATE
×
Maximum Phase:
4
First Approval:
None
UNII:
Molecule Type:
Combination
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
CARBOXYMETHYLCELLULOSE
4
Unknown
Approved
Unknown
Unknown
Unknown
Unknown
CARBOXYMETHYLCELLULOSE
×
Maximum Phase:
4
First Approval:
None
UNII:
Molecule Type:
Unknown
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
INJECTAFER
4
Unknown
Approved
Unknown
Unknown
Unknown
Unknown
INJECTAFER
×
Maximum Phase:
4
First Approval:
None
UNII:
Molecule Type:
Unknown
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
IODIPAMIDE MEGLUMINE
4
Small molecule
Approved
OTHER
INJECTION
Unknown
Unknown
IODIPAMIDE MEGLUMINE
×
Maximum Phase:
4
First Approval:
None
UNII:
X064O0Y1A4
Molecule Type:
Small molecule
Molecular Formula:
C34H48I6N4O16
Molecular Weight:
1530.19
AlogP:
None
PSA:
None
HBD:
None
HBA:
#RotB:
None
Source:
AMLODIPINE BESYLATE; BENAZEPRIL HYDROCHLORIDE
4
Combination
Approved
OTHER
ORAL
Unknown
Unknown
AMLODIPINE BESYLATE; BENAZEPRIL HYDROCHLORIDE
×
Maximum Phase:
4
First Approval:
None
UNII:
Molecule Type:
Combination
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
KRX-0502
4
Small molecule
Approved
Unknown
Unknown
Unknown
Unknown
KRX-0502
×
Maximum Phase:
4
First Approval:
None
UNII:
Molecule Type:
Small molecule
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
FLUNITRAZEPAM
4
Small molecule
Approved
Unknown
Unknown
Unknown
GABA-A receptor; anion channel positive allosteric modulator
FLUNITRAZEPAM
×
Maximum Phase:
4
First Approval:
None
UNII:
620X0222FQ
Molecule Type:
Small molecule
Molecular Formula:
C16H12FN3O3
Molecular Weight:
313.29
AlogP:
2.55
PSA:
75.81
HBD:
0.0
HBA:
#RotB:
2.0
Source:
IMLIFIDASE
4
Enzyme
Unknown
Unknown
Unknown
Anti-Glomerular Basement Membrane Disease; Graft vs Host Disease; Purpura, Thrombocytopenic, Idiopathic; Renal Insufficiency, Chronic; Immune System Diseases
Antibodies hydrolytic enzyme
IMLIFIDASE
×
Maximum Phase:
4
First Approval:
None
UNII:
UVJ7NL8S2P
Molecule Type:
Enzyme
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
LOTEPREDNOL ETABONATE; TOBRAMYCIN
4
Combination
Approved
OTHER
OPHTHALMIC
Unknown
Unknown
LOTEPREDNOL ETABONATE; TOBRAMYCIN
×
Maximum Phase:
4
First Approval:
None
UNII:
Molecule Type:
Combination
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
METFORMIN HYDROCHLORIDE; SITAGLIPTIN PHOSPHATE
4
Combination
Approved
OTHER
ORAL
Unknown
Unknown
METFORMIN HYDROCHLORIDE; SITAGLIPTIN PHOSPHATE
×
Maximum Phase:
4
First Approval:
None
UNII:
Molecule Type:
Combination
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
ALENDRONATE SODIUM; CHOLECALCIFEROL
4
Combination
Approved
OTHER
ORAL
Unknown
Unknown
ALENDRONATE SODIUM; CHOLECALCIFEROL
×
Maximum Phase:
4
First Approval:
None
UNII:
Molecule Type:
Combination
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
OZONE
4
Small molecule
Approved
Unknown
Unknown
Coronary Disease; Cystitis, Interstitial; Diabetes Mellitus; Severe Acute Respiratory Syndrome
Unknown
OZONE
×
Maximum Phase:
4
First Approval:
None
UNII:
66H7ZZK23N
Molecule Type:
Small molecule
Molecular Formula:
O3
Molecular Weight:
48.0
AlogP:
-1.12
PSA:
51.43
HBD:
0.0
HBA:
#RotB:
0.0
Source:
ALPHA-TOCOPHEROL ACETATE; ASCORBIC ACID; BIOTIN; CHOLECALCIFEROL; CYANOCOBALAMIN; DEXPANTHENOL; FOLIC ACID; NIACINAMIDE; PYRIDOXINE HYDROCHLORIDE; RIBOFLAVIN 5'-PHOSPHATE SODIUM; THIAMINE HYDROCHLORIDE; VITAMIN A PALMITATE; VITAMIN K
4
Combination
Approved
OTHER
INTRAVENOUS
Unknown
Unknown
ALPHA-TOCOPHEROL ACETATE; ASCORBIC ACID; BIOTIN; CHOLECALCIFEROL; CYANOCOBALAMIN; DEXPANTHENOL; FOLIC ACID; NIACINAMIDE; PYRIDOXINE HYDROCHLORIDE; RIBOFLAVIN 5'-PHOSPHATE SODIUM; THIAMINE HYDROCHLORIDE; VITAMIN A PALMITATE; VITAMIN K
×
Maximum Phase:
4
First Approval:
None
UNII:
Molecule Type:
Combination
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
COLESTIPOL
4
Unknown
Approved
Unknown
Unknown
Unknown
Unknown
COLESTIPOL
×
Maximum Phase:
4
First Approval:
None
UNII:
Molecule Type:
Unknown
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
GLYCYRRHETINIC ACID
4
Small molecule
Approved
Unknown
Unknown
Unknown
Unknown
GLYCYRRHETINIC ACID
×
Maximum Phase:
4
First Approval:
None
UNII:
Molecule Type:
Small molecule
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
TECHNETIUM TC-99M OXIDRONATE KIT
4
Small molecule
Approved
OTHER
INJECTION
Unknown
Unknown
TECHNETIUM TC-99M OXIDRONATE KIT
×
Maximum Phase:
4
First Approval:
None
UNII:
Molecule Type:
Small molecule
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
NORETHINDRONE; ETHINYL ESTRADIOL
4
Combination
Approved
OTHER
ORAL
Unknown
Unknown
NORETHINDRONE; ETHINYL ESTRADIOL
×
Maximum Phase:
4
First Approval:
None
UNII:
Molecule Type:
Combination
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
COLISTIN SULFATE; HYDROCORTISONE ACETATE; NEOMYCIN SULFATE; THONZONIUM BROMIDE
4
Combination
Approved
OTHER
OTIC
Unknown
Unknown
COLISTIN SULFATE; HYDROCORTISONE ACETATE; NEOMYCIN SULFATE; THONZONIUM BROMIDE
×
Maximum Phase:
4
First Approval:
None
UNII:
Molecule Type:
Combination
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
HYDROCHLOROTHIAZIDE; LABETALOL HYDROCHLORIDE
4
Combination
Approved
OTHER
ORAL
Unknown
Unknown
HYDROCHLOROTHIAZIDE; LABETALOL HYDROCHLORIDE
×
Maximum Phase:
4
First Approval:
None
UNII:
Molecule Type:
Combination
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
EMTRICITABINE; RILPIVIRINE HYDROCHLORIDE; TENOFOVIR DISOPROXIL FUMARATE
4
Combination
Approved
IMMUNE SYSTEM
ORAL
Unknown
Unknown
EMTRICITABINE; RILPIVIRINE HYDROCHLORIDE; TENOFOVIR DISOPROXIL FUMARATE
×
Maximum Phase:
4
First Approval:
None
UNII:
Molecule Type:
Combination
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
FLURANDRENOLIDE; NEOMYCIN SULFATE
4
Combination
Approved
OTHER
TOPICAL
Unknown
Unknown
FLURANDRENOLIDE; NEOMYCIN SULFATE
×
Maximum Phase:
4
First Approval:
None
UNII:
Molecule Type:
Combination
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
INSULIN GLARGINE RECOMBINANT
4
Unknown
Approved
Unknown
Unknown
Unknown
Unknown
INSULIN GLARGINE RECOMBINANT
×
Maximum Phase:
4
First Approval:
None
UNII:
Molecule Type:
Unknown
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
EMPAGLIFLOZIN;METFORMIN HYDROCHLORIDE
4
Combination
Approved
Unknown
Unknown
Unknown
Unknown
EMPAGLIFLOZIN;METFORMIN HYDROCHLORIDE
×
Maximum Phase:
4
First Approval:
None
UNII:
Molecule Type:
Combination
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
1
2
…
269
270
271
272
273
274
275
…
304
305
Next »
Download Option
Close
Header
Compound Name
Maximum Phase
Compound Structure
Smile
Inchi
InchiKey
Compound Properties
Molecular Formula
Molecular Weight
ALogP
PSA